SRNE Start new rallie?
Updated
I think that in final of August SRNE start a new rallie, I hope that start early than I think.
On the graph you can see my prediction lines :
Red -> Resistance that if overcome will become support.
Orange -> Our resistance lines that we try to broke, I think that will broke the bearish trend almost late Agust, September 1th and we take over the line of 9,5$ resistance. 9,5$ will pass to do our support.
Yellow -> Our bulish trend and our major resistance and support lines.
At that moment we will have a Golden Cross if the trend remains bullish, in addition the MACD indicator seems to want to turn around.
God luck to all!
On the graph you can see my prediction lines :
Red -> Resistance that if overcome will become support.
Orange -> Our resistance lines that we try to broke, I think that will broke the bearish trend almost late Agust, September 1th and we take over the line of 9,5$ resistance. 9,5$ will pass to do our support.
Yellow -> Our bulish trend and our major resistance and support lines.
At that moment we will have a Golden Cross if the trend remains bullish, in addition the MACD indicator seems to want to turn around.
God luck to all!
Note
We have two studies that will finish on 31 August and 1 of September more and less.clinicaltrials.gov/ct2/show/record/NCT00804154?id=NCT00804154&draw=2&rank=1&load=cart
clinicaltrials.gov/ct2/show/record/NCT03464916
If we get good news we could see a jump towards 11$ and there we will see if it breaks the resistance or as it has done in other occasions we go down again.
Good luck to all, the news is comming!
Note
Bad days, I think that we going to our Yellow line before October 10th.The last time that the price touched the Yellow line, go up 4$ in one month, I hope that.
We will continue like this until there is no new news.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.